Skip to main content
Premium Trial:

Request an Annual Quote

Protagen Closes $4.2M Financing Round

NEW YORK, May 8 (GenomeWeb News) - Protagen said today that it has closed its second round of financing, raising €3.3 million ($4.2 million).

According to the protein biochip developer, the financing round included both new and existing investors. Proceeds of the financing will be used to expand the company's sales activities in Europe and the US, as well as to broaden its product pipeline.  

 

Investors in the financing round included S-Venture Capital Dortmund and MIG AG Funds 1 and 3.

 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.